Cas:165682-76-8 2-(2-methylanilino)-1,3-thiazole-4-carboxylic acid manufacturer & supplier

We serve Chemical Name:2-(2-methylanilino)-1,3-thiazole-4-carboxylic acid CAS:165682-76-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(2-methylanilino)-1,3-thiazole-4-carboxylic acid

Chemical Name:2-(2-methylanilino)-1,3-thiazole-4-carboxylic acid
CAS.NO:165682-76-8
Synonyms:2-o-Tolylamino-thiazole-4-carboxylic acid
Molecular Formula:C11H10N2O2S
Molecular Weight:234.27400
HS Code:2934100090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:90.46000
Exact Mass:234.04600
LogP:2.96630

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-o-Tolylamino-thiazole-4-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-o-Tolylamino-thiazole-4-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-o-Tolylamino-thiazole-4-carboxylic acid Use and application,2-o-Tolylamino-thiazole-4-carboxylic acid technical grade,usp/ep/jp grade.


Related News: The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 2-(2-methylanilino)-1,3-thiazole-4-carboxylic acid manufacturer The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 2-(2-methylanilino)-1,3-thiazole-4-carboxylic acid supplier Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more. 2-(2-methylanilino)-1,3-thiazole-4-carboxylic acid vendor The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 2-(2-methylanilino)-1,3-thiazole-4-carboxylic acid factory This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies.